Update: 25.02.2025
Last week: 7 week 2024 (10.02.2025 - 16.02.2025)
Last full month: January 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 450 | 8.5% | 12.3% | 0 | 20 736 497 | 8.8% | 9.3% | 0 | 8.5% |
| MoM | 33 837 | -14.9% | 12.9% | -0.6 | 69 344 094 | -8.9% | 9.3% | -0.2 | -11.2% |
| YTD | 56 410 | 25.4% | 12.8% | 1.7 | 118 158 855 | 17.3% | 9.4% | -0.2 | 8.3% |
| MAT | 432 870 | 23.6% | 12.5% | 3.2 | 856 481 692 | 23.5% | 9.3% | 1.3 | -7.6% |
| BRAINMAX | |||||||||
| WoW | 2 354 | 1.4% | 100.0% | 0 | 8 287 814 | 3.3% | 100.0% | 0 | 1.4% |
| MoM | 8 486 | -17.2% | 100.0% | 0 | 30 256 382 | -13.9% | 100.0% | 0 | -17.2% |
| YTD | 14 285 | 113.0% | 100.0% | 0 | 50 529 736 | 110.7% | 100.0% | 0 | 113.0% |
| MAT | 90 246 | 81.5% | 100.0% | 0 | 313 269 595 | 81.3% | 100.0% | 0 | 81.5% |
| GOLDLINE PLUS | |||||||||
| WoW | 17 583 | 10.8% | 44.9% | 0.5 | 57 432 826 | 9.6% | 36.4% | -0.2 | 9.7% |
| MoM | 65 341 | 9.4% | 45.4% | -1.2 | 211 436 517 | 11.8% | 37.6% | -0.3 | 12.2% |
| YTD | 106 311 | -3.4% | 45.2% | 1.6 | 345 831 236 | -3.2% | 37.2% | 1.3 | -6.8% |
| MAT | 825 366 | -5.7% | 45.7% | 0.4 | 2 591 427 626 | -5.3% | 37.3% | -2.1 | -6.6% |
| MIGRENIUM | |||||||||
| WoW | 9 506 | 3.8% | 0.4% | 0 | 3 273 043 | 4.3% | 0.5% | 0 | 5.0% |
| MoM | 33 141 | -10.0% | 0.3% | 0 | 11 562 682 | -10.1% | 0.5% | 0 | -4.3% |
| YTD | 56 173 | -33.3% | 0.4% | -0.2 | 19 494 645 | -14.6% | 0.5% | -0.1 | -1.0% |
| MAT | 539 764 | -16.1% | 0.5% | -0.1 | 178 322 656 | 36.5% | 0.6% | 0.1 | 0.7% |
| MODELAX-N | |||||||||
| WoW | 36 758 | 4.7% | 23.4% | 0.5 | 18 872 328 | 4.4% | 16.6% | 0.3 | 2.6% |
| MoM | 131 900 | 12.7% | 21.1% | 2.5 | 67 843 771 | 14.2% | 14.8% | 1.8 | -0.4% |
| YTD | 219 964 | 10.7% | 21.8% | 0.7 | 113 066 671 | 42.3% | 15.3% | 2.6 | 6.9% |
| MAT | 1 484 763 | 19.4% | 21.8% | 2.6 | 692 901 093 | 64.2% | 14.5% | 3.7 | 5.3% |
| REDUXIN | |||||||||
| WoW | 12 806 | 10.1% | 32.7% | 0.1 | 71 330 274 | 11.3% | 45.2% | 0.5 | 9.7% |
| MoM | 45 654 | 12.6% | 31.7% | 0.1 | 244 184 975 | 11.5% | 43.5% | -0.4 | 12.2% |
| YTD | 75 266 | -11.6% | 32.0% | -1.8 | 407 614 635 | -11.7% | 43.9% | -2.6 | -6.8% |
| MAT | 585 567 | -7.8% | 32.4% | -0.4 | 3 109 242 824 | 5.0% | 44.8% | 2.1 | -6.6% |
| REDUXIN FORTE | |||||||||
| WoW | 4 040 | 8.1% | 10.3% | -0.1 | 18 043 459 | 9.4% | 11.4% | -0.1 | 9.7% |
| MoM | 14 054 | 12.6% | 9.8% | 0 | 63 041 555 | 12.9% | 11.2% | 0 | 12.2% |
| YTD | 23 558 | 7.0% | 10.0% | 1.3 | 105 482 409 | 7.7% | 11.4% | 1.5 | -6.8% |
| MAT | 168 892 | 0.7% | 9.3% | 0.7 | 729 256 630 | 7.7% | 10.5% | 0.7 | -6.6% |
| SALVISAR | |||||||||
| WoW | 17 939 | 6.8% | 2.3% | 0 | 8 577 140 | 6.8% | 2.2% | 0 | 5.0% |
| MoM | 54 730 | -5.1% | 1.8% | -0.1 | 25 850 376 | -1.0% | 1.7% | 0 | -2.3% |
| YTD | 96 538 | 72.5% | 1.9% | 0.9 | 45 751 739 | 130.6% | 1.8% | 1 | -4.6% |
| MAT | 612 369 | 27.7% | 1.6% | 0.4 | 266 849 845 | 67.3% | 1.5% | 0.5 | -6.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 56 410 | 25.4% | 12.8% | 1.7 | 118 158 855 | 17.3% | 9.4% | -0.2 | 8.3% |
| BRAINMAX | 14 285 | 113.0% | 100.0% | 0 | 50 529 736 | 110.7% | 100.0% | 0 | 113.0% |
| GOLDLINE PLUS | 106 311 | -3.4% | 45.2% | 1.6 | 345 831 236 | -3.2% | 37.2% | 1.3 | -6.8% |
| MIGRENIUM | 56 173 | -33.3% | 0.4% | -0.2 | 19 494 645 | -14.6% | 0.5% | -0.1 | -1.0% |
| MODELAX-N | 219 964 | 10.7% | 21.8% | 0.7 | 113 066 671 | 42.3% | 15.3% | 2.6 | 6.9% |
| REDUXIN CAPS | 75 266 | -11.6% | 32.0% | -1.8 | 407 614 635 | -11.7% | 43.9% | -2.6 | -6.8% |
| REDUXIN FORTE | 23 558 | 7.0% | 10.0% | 1.3 | 105 482 409 | 7.7% | 11.4% | 1.5 | -6.8% |
| SALVISAR | 96 538 | 72.5% | 1.9% | 0.9 | 45 751 739 | 130.6% | 1.8% | 1 | -4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 432 870 | 23.6% | 12.5% | 3.2 | 856 481 692 | 23.5% | 9.3% | 1.3 | -7.6% |
| BRAINMAX | 90 246 | 81.5% | 100.0% | 0 | 313 269 595 | 81.3% | 100.0% | 0 | 81.5% |
| GOLDLINE PLUS | 825 366 | -5.7% | 45.7% | 0.4 | 2 591 427 626 | -5.3% | 37.3% | -2.1 | -6.6% |
| MIGRENIUM | 539 764 | -16.1% | 0.5% | -0.1 | 178 322 656 | 36.5% | 0.6% | 0.1 | 0.7% |
| MODELAX-N | 1 484 763 | 19.4% | 21.8% | 2.6 | 692 901 093 | 64.2% | 14.5% | 3.7 | 5.3% |
| REDUXIN CAPS | 585 567 | -7.8% | 32.4% | -0.4 | 3 109 242 824 | 5.0% | 44.8% | 2.1 | -6.6% |
| REDUXIN FORTE | 168 892 | 0.7% | 9.3% | 0.7 | 729 256 630 | 7.7% | 10.5% | 0.7 | -6.6% |
| SALVISAR | 612 369 | 27.7% | 1.6% | 0.4 | 266 849 845 | 67.3% | 1.5% | 0.5 | -6.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 450 | 8.5% | 12.3% | 0 | 20 736 497 | 8.8% | 9.3% | 0 | 8.5% |
| BRAINMAX | 2 354 | 1.4% | 100.0% | 0 | 8 287 814 | 3.3% | 100.0% | 0 | 1.4% |
| GOLDLINE PLUS | 17 583 | 10.8% | 44.9% | 0.5 | 57 432 826 | 9.6% | 36.4% | -0.2 | 9.7% |
| MIGRENIUM | 9 506 | 3.8% | 0.4% | 0 | 3 273 043 | 4.3% | 0.5% | 0 | 5.0% |
| MODELAX-N | 36 758 | 4.7% | 23.4% | 0.5 | 18 872 328 | 4.4% | 16.6% | 0.3 | 2.6% |
| REDUXIN CAPS | 12 806 | 10.1% | 32.7% | 0.1 | 71 330 274 | 11.3% | 45.2% | 0.5 | 9.7% |
| REDUXIN FORTE | 4 040 | 8.1% | 10.3% | -0.1 | 18 043 459 | 9.4% | 11.4% | -0.1 | 9.7% |
| SALVISAR | 17 939 | 6.8% | 2.3% | 0 | 8 577 140 | 6.8% | 2.2% | 0 | 5.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 33 837 | -14.9% | 12.9% | -0.6 | 69 344 094 | -8.9% | 9.3% | -0.2 | -11.2% |
| BRAINMAX | 8 486 | -17.2% | 100.0% | 0 | 30 256 382 | -13.9% | 100.0% | 0 | -17.2% |
| GOLDLINE PLUS | 65 341 | 9.4% | 45.4% | -1.2 | 211 436 517 | 11.8% | 37.6% | -0.3 | 12.2% |
| MIGRENIUM | 33 141 | -10.0% | 0.3% | 0 | 11 562 682 | -10.1% | 0.5% | 0 | -4.3% |
| MODELAX-N | 131 900 | 12.7% | 21.1% | 2.5 | 67 843 771 | 14.2% | 14.8% | 1.8 | -0.4% |
| REDUXIN CAPS | 45 654 | 12.6% | 31.7% | 0.1 | 244 184 975 | 11.5% | 43.5% | -0.4 | 12.2% |
| REDUXIN FORTE | 14 054 | 12.6% | 9.8% | 0 | 63 041 555 | 12.9% | 11.2% | 0 | 12.2% |
| SALVISAR | 54 730 | -5.1% | 1.8% | -0.1 | 25 850 376 | -1.0% | 1.7% | 0 | -2.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs